News
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - Wegovy users could lose more than 10% of their body weight after a year on the ...
MHRA has issued new guidance warning women taking weight-loss injections to ensure they are also using effective ...
Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...
A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results